Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Comparison of intravenous and oral magnesium replacement in hospitalized patients with cardiovascular disease.

Reed BN, Zhang S, Marron JS, Montague D.

Am J Health Syst Pharm. 2012 Jul 15;69(14):1212-7. doi: 10.2146/ajhp110574.

PMID:
22761075
2.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

3.

Magnesium: a discussion of its role in the treatment of ventricular dysrhythmia.

Boriss MN, Papa L.

Crit Care Med. 1988 Mar;16(3):292-3. Review. No abstract available.

PMID:
3277786
4.

Comparison of intramuscular magnesium sulfate with low dose intravenous magnesium sulfate regimen for treatment of eclampsia.

Chowdhury JR, Chaudhuri S, Bhattacharyya N, Biswas PK, Panpalia M.

J Obstet Gynaecol Res. 2009 Feb;35(1):119-25. doi: 10.1111/j.1447-0756.2008.00842.x.

PMID:
19215558
5.

Effects of intravenous magnesium sulfate on arrhythmias in patients with congestive heart failure.

Gottlieb SS, Fisher ML, Pressel MD, Patten RD, Weinberg M, Greenberg N.

Am Heart J. 1993 Jun;125(6):1645-50.

PMID:
8498307
6.

Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.

Caron MF, Kluger J, Tsikouris JP, Ritvo A, Kalus JS, White CM.

Pharmacotherapy. 2003 Mar;23(3):296-300.

PMID:
12627926
7.

Prophylactic intravenous magnesium sulphate in addition to oral {beta}-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial.

Cook RC, Humphries KH, Gin K, Janusz MT, Slavik RS, Bernstein V, Tholin M, Lee MK.

Circulation. 2009 Sep 15;120(11 Suppl):S163-9. doi: 10.1161/CIRCULATIONAHA.108.841221.

8.

Functional magnesium deficiency in critically ill patients identified using a magnesium-loading test.

Hébert P, Mehta N, Wang J, Hindmarsh T, Jones G, Cardinal P.

Crit Care Med. 1997 May;25(5):749-55.

PMID:
9187591
9.

The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting.

Hazelrigg SR, Boley TM, Cetindag IB, Moulton KP, Trammell GL, Polancic JE, Shawgo TS, Quin JA, Verhulst S.

Ann Thorac Surg. 2004 Mar;77(3):824-30.

PMID:
14992881
10.

Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial.

McWhorter J, Carlan SJ, OLeary TD, Richichi K, OBrien WF.

Obstet Gynecol. 2004 May;103(5 Pt 1):923-30. Erratum in: Obstet Gynecol. 2004 Jul;104(1):200.

PMID:
15121566
11.

Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.

Kalus JS, Spencer AP, Tsikouris JP, Chung JO, Kenyon KW, Ziska M, Kluger J, White CM.

Am J Health Syst Pharm. 2003 Nov 15;60(22):2308-12.

PMID:
14652979
12.

Three-day magnesium administration prevents atrial fibrillation after coronary artery bypass grafting.

Kohno H, Koyanagi T, Kasegawa H, Miyazaki M.

Ann Thorac Surg. 2005 Jan;79(1):117-26. Review.

PMID:
15620927
14.

[Causes and treatment of hypomagnesemia].

Yamamoto M, Yamaguchi T.

Clin Calcium. 2007 Aug;17(8):1241-8. Review. Japanese.

PMID:
17660622
15.
16.

Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.

Shah QA, Memon MZ, Suri MF, Rodriguez GJ, Kozak OS, Taylor RA, Tummala RP, Vazquez G, Georgiadis AL, Qureshi AI.

Neurocrit Care. 2009;11(2):190-8. doi: 10.1007/s12028-009-9209-9. Epub 2009 Apr 16.

PMID:
19370322
17.

Changes in cerebrospinal fluid magnesium levels in patients undergoing spinal anaesthesia for hip arthroplasty: does intravenous infusion of magnesium sulphate make any difference? A prospective, randomized, controlled study.

Mercieri M, De Blasi RA, Palmisani S, Forte S, Cardelli P, Romano R, Pinto G, Arcioni R.

Br J Anaesth. 2012 Aug;109(2):208-15. doi: 10.1093/bja/aes146. Epub 2012 Jun 1.

PMID:
22661752
18.

Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia.

Magee LA, Miremadi S, Li J, Cheng C, Ensom MH, Carleton B, Côté AM, von Dadelszen P.

Am J Obstet Gynecol. 2005 Jul;193(1):153-63.

PMID:
16021073
19.
20.

Pulmonary function of preeclamptic women receiving intravenous magnesium sulfate seizure prophylaxis.

Herpolsheimer A, Brady K, Yancey MK, Pandian M, Duff P.

Obstet Gynecol. 1991 Aug;78(2):241-4.

PMID:
2067769

Supplemental Content

Support Center